Khalid Nabilsi

Experience: Following his appointment to the Board of Hikma in December 2025, Khalid was appointed as Deputy CEO, North America and Europe in February 2026. In this role Khalid oversees Hikma’s activities in North America and Europe and is accountable for delivering both the Hikma Rx and Injectables North America and Europe results. Prior to his current role, Khalid served as Chief Financial Officer from 2011 to 2026, with responsibility for Group finance, including reporting and capital management. Khalid has held several leadership positions within Hikma’s financial functions during 24 years with Hikma, including VP Finance.

Qualifications: Certified Public Accountant. MBA from the University of Hull.

Other appointments: Non-Executive Director at Capital Bank, Jordan.